Skip to main content
SpringerLink
Log in

Update on Obstructive Sleep Apnea and Its Associated Metabolic Abnormalities: Insulin Resistance, Metabolic Syndrome, and Type 2 Diabetes Mellitus

  • Published:
Current Cardiovascular Risk Reports Aims and scope Submit manuscript

Abstract

Obstructive sleep apnea is characterized by repeated episodes of upper airway collapse during sleep, leading to apneic and hypopneic episodes, oxygen desaturation, and sleep fragmentation. This condition is closely associated with features of “metabolic syndrome” as well as overt diabetes. Although the association of metabolic abnormalities clearly portend increased cardiovascular risk, it remains unclear to what extent obesity confounds these associations. Attempts to demonstrate a causal relationship between obstructive sleep apnea and insulin resistance have yielded conflicting results. Although several recent studies have demonstrated a relationship between obstructive sleep apnea and diabetes mellitus independent of obesity, there are currently limited data demonstrating a strong causative link. The currently proposed pathophysiology involves intermittent hypoxia, sleep fragmentation, sympathetic activation, oxidative stress, an increase in proinflammatory adipocytokines, and hyperleptinemia and leptin resistance. Although continuous positive airway pressure has shown promise in treating obstructive sleep apnea and its associated metabolic derangements, two recent large, randomized controlled trials have redoubled the emphasis on weight loss in treating the triad of metabolic syndrome, diabetes, and obstructive sleep apnea. Weight loss and aggressive lifestyle intervention remain a common treatment modality for all of these conditions and should always be considered first-line treatment for this clinical construct.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as:• Of importance •• Of major importance

  1. Young T, Palta M, Dempsey J, et al.: The occurrence of sleep-disordered breathing among middle-aged adults. N Engl J Med 1993, 328:1230–1235.

    Article  CAS  PubMed  Google Scholar 

  2. Punjabi NM, Caffo BS, Goodwin JL, et al.: Sleep-disordered breathing and mortality: a prospective cohort study. PLoS Med 2009, 6:e1000132.

    Article  PubMed  Google Scholar 

  3. Newman AB, Nieto FJ, Guidry U, et al.: Relation of sleep-disordered breathing to cardiovascular risk factors: The Sleep Heart Health Study. Am J Epidemiol 2001, 154:10–59.

    Article  Google Scholar 

  4. National Center for Chronic Disease Prevention & Health Promotion: Behavioral Risk Factor Surveillance System, Prevalence and trends data. Available at: http://www.cdc.gov/brfss . Accessed May 17, 2009.

  5. • Alberti KG, Eckel RH, Grundy SM, et al.: Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 2009, 120:1640–1645. This is a landmark article in the evolving diagnostic criteria for metabolic syndrome. The new criteria are a result of discussions by the major relevant international organizations and aim to produce one set of criteria that can be used in any population.

    Article  CAS  PubMed  Google Scholar 

  6. Blaha M, Elasy T: Clinical use of the metabolic syndrome: why the confusion? Clin Diabetes 2006, 24:125–131.

    Article  Google Scholar 

  7. Reichmuth KJ, Austin D, Skatrud JB, Young T: Association of sleep apnea and type 2 diabetes: a population-based study. Am J Respir Crit Care Med 2005, 172:1590–1595.

    Article  PubMed  Google Scholar 

  8. Wilcox I, McNamara SG, Collins FL, et al.: “Syndrome Z”: the interaction of sleep apnea, vascular risk factors and heart disease. Thorax 1998, 53(Suppl 3):S25–S28.

    PubMed  Google Scholar 

  9. • Tasali E, Mokhlesi B, Van Cauter E: Obstructive sleep apnea and type 2 diabetes: interacting epidemics. Chest 2008, 133:496–506. This review article provides a thorough literature search on the different types of studies of the relationship between obstructive sleep apnea and diabetes mellitus.

    Article  PubMed  Google Scholar 

  10. Chasens E: Obstructive sleep apnea, daytime sleepiness and type 2 diabetes. The Diabetes Educator 2007, 33:475–482.

    Article  PubMed  Google Scholar 

  11. •• Foster GD, Sanders MH, Millman R, et al.: Obstructive sleep apnea among obese patients with type 2 diabetes. Diabetes Care 2009, 32:1017–1019. This recent study assess the risk factors for the presence and severity of obstructive sleep apnea among obese patients with type 2 diabetes. The patient population represents the Sleep AHEAD (Action for Health in Diabetes) study, a four-site ancillary study of the Look AHEAD Trial.

    Article  PubMed  Google Scholar 

  12. Bonora E, Targher G, Alberiche M, et al.: Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity. Studies in subjects with various degrees of glucose tolerance and insulin sensitivity. Diabetes Care 2000, 23:57–63.

    CAS  Google Scholar 

  13. Punjabi NM, Shahar E, Redline S, et al.: Sleep-disordered breathing, glucose intolerance, and insulin resistance: The Sleep Heart Health Study. Am J Epidemiol 2004, 160:521–530.

    Article  PubMed  Google Scholar 

  14. Punjabi N, Beamer B: Sleep apnea and metabolic dysfunction. In Principles and Practice of Sleep Medicine. Edited by Kryger M, Roth T, Dement W. Philadelphia: WB Saunders; 2005:1034–1042.

    Google Scholar 

  15. International Diabetes Federation: The IDF consensus worldwide definition of the metabolic syndrome. Available at: http://www.idf.org/webdata/docs/Metac_syndrome_def.pdf. Accessed June 10, 2005.

  16. Grundy S, Becker D, Clark L, et al.: Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. JAMA 2001, 285:2486–2497.

    Article  Google Scholar 

  17. Tkacova R, Dorkova Z, Molcanyiova A, et al.: Cardiovascular risk and insulin resistance in patients with obstructive sleep apnea. Med Sci Monit 2008, 14:CR438–CR444.

    Google Scholar 

  18. Polotsky VY, Patil SP, Savransky V, et al.: Obstructive sleep apnea, insulin resistance and steatohepatitis in severe obesity. Am J Respir Crit Care Med 2009, 179:228–234. (Published erratum appears in Am J Respir Crit Care Med 2009, 180:910–911.)

    Google Scholar 

  19. Gruber A, Horwood F, Sithole J, et al.: Obstructive sleep apnea is independently associated with the metabolic syndrome but not insulin resistance state. Cardiovas Diabetol 2006, 5:22.

    Article  CAS  Google Scholar 

  20. Onat A, Hergenc G, Urayel H, et al.: Obstructive sleep apnea syndrome is associated with metabolic syndrome rather than insulin resistance. Sleep Breath 2007, 11:23–30.

    Article  PubMed  Google Scholar 

  21. Kono M, Tatsumi K, Saibara T, et al.: Obstructive sleep apnea is associated with some components of the metabolic syndrome. Chest 2007, 131:1387–1392.

    Article  CAS  PubMed  Google Scholar 

  22. Parish JM, Adam T, Facchiano L: Relationship of metabolic syndrome and obstructive sleep apnea. J Clin Sleep Med 2007, 3:467–472.

    PubMed  Google Scholar 

  23. Sharma SK, Kumpawat S, Goel A, et al.: Obesity, and not obstructive sleep apnea, is responsible for metabolic abnormalities in a cohort with sleep-disordered breathing. Sleep Med 2007, 8:12–17.

    Article  CAS  PubMed  Google Scholar 

  24. Tamura A, Kawano Y, Watanabe T, Kadota J: Relationship between the severity of obstructive sleep apnea and impaired glucose metabolism in patients with obstructive sleep apnea. Resp Med 2008, 102:1412–1416.

    Article  Google Scholar 

  25. Lindberg E, Berne C, Franklin KA, et al.: Snoring and daytime sleepiness as risk factors for hypertension and diabetes in women: a population-based study. Resp Med 2007, 101:1283–1290.

    Article  Google Scholar 

  26. •• Seicean S, Kirchner HL, Gottlieb DJ, et al.: Sleep-disordered breathing and impaired glucose metabolism in normal weight and overweight/obese individuals: the Sleep Heart Health Study. Diabet Care 2008, 31:1001–1006. This is an important study in the sleep apnea field because it forms part of the largest cohort being conducted in obstructive sleep apnea. This study addresses one of the present controversies: is the risk of diabetes in obstructive sleep apnea due to the confounding effect of obesity? Sleep-disordered breathing was associated with occult diabetes and impaired fasting glucose after adjusting for age, gender, race, body mass index, and waist circumference.

    Article  Google Scholar 

  27. • Marshall NS, Wong KK, Phillips CL, et al.: Is sleep apnea an independent risk factor for prevalent and incident diabetes in the Busselton health study? J Clin Sleep Med 2009, 5:15–20. This study was instrumental because it attempted to determine if there was in fact a causal association between obstructive sleep apnea and diabetes. Moderate to severe sleep apnea was found to be a significant risk factor for incident diabetes in this Australian population-based cohort.

    PubMed  Google Scholar 

  28. Yamauchi M, Nakano H, Maekawa J, et al.: Oxidative stress in obstructive sleep apnea. Chest 2005, 127:1674–1679.

    Article  CAS  PubMed  Google Scholar 

  29. • Lavie L: Oxidative stress: a unifying paradigm in obstructive sleep apnea and comorbidities. Prog Cardiovasc Dis 2009, 51:303–312. This review article provides a concise summary of the major pathophysiologic factors thought to associate obstructive sleep apnea with insulin resistance and diabetes mellitus.

    Article  CAS  PubMed  Google Scholar 

  30. Iiyori N, Alonso LC, Li J, et al.: Intermittent hypoxia causes insulin resistance in lean mice independent of autonomic activity. Am J Respir Crit Care Med 2007, 175:851–857.

    Article  CAS  PubMed  Google Scholar 

  31. Ye J: Emerging role of adipose tissue hypoxia in obesity and insulin resistance. Int J Obesity 2009, 33:54–66.

    Article  CAS  Google Scholar 

  32. •• Arnardottir E, Mackiewicz M, Gislason T, et al.: Molecular signatures of obstructive sleep apnea in adults: a review and perspective. Sleep 2009, 32:447–470. This article provides a comprehensive backdrop of the latest molecular advances in etiology and pathophysiology of obstructive sleep apnea and co-morbidities.

    PubMed  Google Scholar 

  33. Ryan S, Taylor CT, McNicholas WT: Predictors of elevated nuclear factor-kB-dependent genes in obstructive sleep apnea syndrome. Am J Respir Crit Care Med 2006, 174:824–830.

    Article  CAS  PubMed  Google Scholar 

  34. Vgontzas AN, Papanicolaou DA, Bixler EO, et al.: Sleep apnea and daytime sleepiness and fatigue: relation to visceral obesity, insulin resistance, and hypercytokinemia. J Clin Endocrinol Metab 2000, 85:1151–1158.

    Article  CAS  PubMed  Google Scholar 

  35. Kapsimalis F, Varouchakis G, Manousaki A, et al.: Association of sleep apnea severity and obesity with insulin resistance, C-reactive protein, and leptin levels in male patients with obstructive sleep apnea. Lung 2008, 186:209–217.

    Article  CAS  PubMed  Google Scholar 

  36. •• Tasali E, Ip MS: Obstructive sleep apnea and metabolic syndrome: alterations in glucose metabolism and inflammation. Proc Am Thorac Soc 2008, 5:207–217. This article provides a thorough holistic insight into various advances in obstructive sleep apnea and glucose metabolism by two experts in the sleep apnea field.

    Article  PubMed  Google Scholar 

  37. Levy P, Bonsignore M, Eckel J: Sleep, sleep-disordered breathing and metabolic consequences. Eur Respir J 2009, 34:243–260.

    Article  CAS  PubMed  Google Scholar 

  38. Lam JC, Ip MS: an update on obstructive sleep apnea and the metabolic syndrome. Curr Opin Pulmonary Med 2007, 13:484–489.

    Article  Google Scholar 

  39. Wiernsperger N, Nivoit P, Bouskela E: Obstructive sleep apnea and insulin resistance: a role for microcirculation? Clinics 2006, 61:253–266.

    Article  PubMed  Google Scholar 

  40. Spiegel K, Tasrali E, Leproult R, Van Cauter E: Effects of poor and short sleep on glucose metabolism and obesity risk. Nat Rev Endocrinol 2009, 5:253–261.

    Article  CAS  PubMed  Google Scholar 

  41. Spiegel K, Knutson K, Leproult R, et al.: Sleep loss: a novel risk factor for insulin resistance and type 2 diabetes. J Appl Physiol 2005, 99:2008–2019.

    Article  CAS  PubMed  Google Scholar 

  42. Pillar G, Shehadeh N: Abdominal fat and sleep apnea:the chicken or the egg? Diabetes Care 2008, 31:S303–S309.

    Article  PubMed  Google Scholar 

  43. Esteve E, Ricart W, Fernandez-Real JM: Adipocytokines and insulin resistance: the possible role of lipocalin-2, retinol binding protein-4 and adiponectin. Diabetes Care 2009, 32:S362–S367.

    Article  CAS  PubMed  Google Scholar 

  44. Lam JC, Xu A, Tam S, et al.: Hypoadiponectinemia is related to sympathetic activation and severity of obstructive sleep apnea. Sleep 2008, 31:1721–1727.

    PubMed  Google Scholar 

  45. Makino S, Fujiwara M, Suzukawa K, et al.: Visceral obesity is associated with the metabolic syndrome and elevated plasma retinol binding protein-4 level in obstructive sleep apnea syndrome. Horm Metab Res 2009, 41:221–226.

    Article  CAS  PubMed  Google Scholar 

  46. Foster GD, Borradaile KE, Sanders MH, et al.: A randomised study on the effect of weight loss on obstructive sleep apnea among obese patients with type 2 diabetes: the Sleep Ahead study. Arch Intern Med 2009, 169:1619–1626.

    Article  PubMed  Google Scholar 

  47. Grunstein RR, Stenlof K, Hedner JA, et al.: Two year reduction in sleep apnea symptoms and associated diabetes incidence after weight loss in severe obesity. Sleep 2007, 30:703–710.

    PubMed  Google Scholar 

  48. •• Blaha MJ, Bansal S, Rouf R, et al.: A practical “ABCDE” approach to the metabolic syndrome. Mayo Clin Proc 2008, 83:932–943. This article delineates a simple step-by-step approach to the treatment of metabolic syndrome. Given the close associations between metabolic syndrome, diabetes mellitus, and obstructive sleep apnea, this therapeutic approach is likely to be invaluable to treatment of sleep apnea patients.

    Article  PubMed  Google Scholar 

  49. • Johansson K, Neovius M, Lagerros YT, et al.: Effect of a very low energy diet on moderate and severe obstructive sleep apnea in obese men: a randomized controlled trial. BMJ 2009, 339:b4609. This randomized controlled trial emphasizes the importance of weight loss strategies in treatment of sleep apnea. Drastic reduction in weight loss was noted, resulting in tremendous improvement in sleep apnea symptoms. Some patients were even deemed to not meet the criteria for diagnosis of sleep apnea at the end of the study period.

    Article  PubMed  Google Scholar 

  50. Babu A, Herdegen J, Fogelfeld L, et al.: Type 2 diabetes, glycemic control, and continuous positive airway pressure in obstructive sleep apnea. Arch Intern Med 2005, 165:447–452.

    Article  PubMed  Google Scholar 

  51. Dawson A, Abel SL, Loving RT, et al.: CPAP therapy of obstructive sleep apnea in type 2 diabetics improves glycemic control during sleep. J Clin Sleep Med 2008, 4:538–542.

    PubMed  Google Scholar 

  52. Cuhadaroglu C, Utkusavas A, Ozturk L, et al.: Effects of nasal CPAP treatment on insulin resistance, lipid profile and plasma leptin in sleep apnea. Lung 2009, 187:75–81.

    Article  CAS  PubMed  Google Scholar 

  53. Schahin SP, Nechanitzky T, Dittel C, et al.: Long term improvement of insulin sensitivity during CPAP therapy in the obstructive sleep apnea syndrome. Med Sci Monit 2008, 14:CR117–CR121.

    Google Scholar 

  54. Hassaballa HA, Tulaimat A, Herdegen JJ, Mokhlesi B: The effect of continuous positive airway pressure on glucose control in diabetic patients with severe obstructive sleep apnea. Sleep Breath 2005, 9:176–180.

    Article  PubMed  Google Scholar 

  55. •• Dorkova Z, Petrasova D, Molcanyiova A, et al.: Effects of continuous positive airway pressure on cardiovascular risk profile in patients with severe obstructive sleep apnea and metabolic syndrome. Chest 2008, 134:686–692. The significance of this study is that it attempts to compare cardiovascular risk in patients before and after therapy with CPAP. This makes the study more practical and applicable than others because it addresses the most fundamental issue about which physicians are concerned, which is cardiovascular risk.

    Article  CAS  PubMed  Google Scholar 

  56. Bazzano LA, Khan Z, Reynolds K, He J: Effect of nocturnal nasal continuous positive airway pressure on blood pressure in obstructive sleep apnea. Hypertension 2007, 50:417–423.

    Article  CAS  PubMed  Google Scholar 

  57. Reaven GM: Banting Lecture 1988: Role of insulin resistance in human disease. Diabetes 1998, 37:1595–1607.

    Article  Google Scholar 

Download references

Disclosure

No potential conflicts of interest relevant to this article were reported.

Author information

Authors and Affiliations

  1. Greater Baltimore Medical Center, 6565 North Charles Street, Towson, MD, 21204, USA

    Rajesh Tota-Maharaj

  2. Johns Hopkins Ciccarone Center for the Prevention of Heart Disease, Johns Hopkins Hospital, 568A Carnegie Building, 600 N. Wolfe Street, Baltimore, MD, 21287, USA

    Roger S. Blumenthal & Michael J. Blaha

Authors
  1. Rajesh Tota-Maharaj
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Roger S. Blumenthal
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Michael J. Blaha
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Michael J. Blaha.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Tota-Maharaj, R., Blumenthal, R.S. & Blaha, M.J. Update on Obstructive Sleep Apnea and Its Associated Metabolic Abnormalities: Insulin Resistance, Metabolic Syndrome, and Type 2 Diabetes Mellitus. Curr Cardio Risk Rep 4, 165–173 (2010). https://doi.org/10.1007/s12170-010-0083-y

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12170-010-0083-y

Keywords

Search

Navigation